Last updated: August 17, 2026

Examiner: TIWARI, VYOMA SHUBHAM

Tech Center 1600 • Art Units: 1633 1634 1638

This examiner grants 30% of resolved cases

Performance Statistics

30.2%

Allow Rate

-29.8% vs TC avg

Total Applications

+46.7%

Interview Lift

1477

Avg Prosecution Days

Based on 53 resolved cases, 2023–2026

2.1%

§101 Eligibility

16.9%

§102 Novelty

39.4%

§103 Obviousness

38.9%

§112 Clarity

App #	Title	Status	Assignee
17218025	TARGETED LIPID PARTICLES AND COMPOSITIONS AND USES THEREOF	Non-Final OA	Flagship Pioneering Innovations V, Inc.
17607354	BEAD-FREE EX-VIVO EXPANSION OF HUMAN REGULATORY T CELLS	Final Rejection	The Regents of the University of California
16929948	High Specificity Genome Editing Using Chemically Modified Guide RNAs	Final Rejection	Agilent Technologies, Inc.
18838822	Biosynthesis Of Linalool	Non-Final OA	AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.